Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susmita Chatterjee

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Cell Stem Cell|January 17, 2017
Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of DiseaseMark P Chao, Andrew J Gentles, Susmita Chatterjee, et al.
The Lancet. Global Health|October 14, 2017
Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling studyStéphane Verguet, Carlos Riumallo-Herl, Gabriela B Gomez, et al.
Frontiers in Nutrition|March 30, 2026
A cluster randomized trial protocol to evaluate the effectiveness of an integrated package of improved take-home foods complemented with social and behaviour change communication strategies to improve nutritional status in children aged 6-36 months in six states of India: NECCTAR trialMrunali Zode, Suparna Ghosh Jerath, Manoja Kumar Das, et al.
The Indian Journal of Medical Research|August 2, 2023
Cost of implementing the QualityRights programme in public hospitals in Gujarat providing mental healthcareSusmita Chatterjee, Soumitra Pathare, Michelle Funk, et al.
BMJ Open|January 14, 2025
Incremental cost of treating antimicrobial-resistant infections among hospitalised patients in India: a cohort studyAbhijit Kadam, Megha Mamulwar, Gayatri Bhambure, et al.
The Lancet. Global Health|October 11, 2016
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine modelsNicolas A Menzies, Gabriela B Gomez, Fiammetta Bozzani, et al.
Nature Medicine|October 20, 2015
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseHui Gao, Joshua M Korn, Stéphane Ferretti, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Cell Stem Cell|January 17, 2017
Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of DiseaseMark P Chao, Andrew J Gentles, Susmita Chatterjee, et al.
The Lancet. Global Health|October 14, 2017
Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling studyStéphane Verguet, Carlos Riumallo-Herl, Gabriela B Gomez, et al.
Frontiers in Nutrition|March 30, 2026
A cluster randomized trial protocol to evaluate the effectiveness of an integrated package of improved take-home foods complemented with social and behaviour change communication strategies to improve nutritional status in children aged 6-36 months in six states of India: NECCTAR trialMrunali Zode, Suparna Ghosh Jerath, Manoja Kumar Das, et al.
The Indian Journal of Medical Research|August 2, 2023
Cost of implementing the QualityRights programme in public hospitals in Gujarat providing mental healthcareSusmita Chatterjee, Soumitra Pathare, Michelle Funk, et al.
BMJ Open|January 14, 2025
Incremental cost of treating antimicrobial-resistant infections among hospitalised patients in India: a cohort studyAbhijit Kadam, Megha Mamulwar, Gayatri Bhambure, et al.
The Lancet. Global Health|October 11, 2016
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine modelsNicolas A Menzies, Gabriela B Gomez, Fiammetta Bozzani, et al.
Nature Medicine|October 20, 2015
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseHui Gao, Joshua M Korn, Stéphane Ferretti, et al.
Pageof 7